Plato Investment Management’s Boston Scientific BSX Stock Holding History

Plato Investment Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.31M	Sell	30,788 -12,384	-29%	-$672K	0.07%	235
2026 Q1	$2.71M	Buy	43,172 +466	+1%	+$37.3K	0.18%	126
2025 Q4	$4.09M	Buy	42,706 +14,144	+50%	+$1.39M	0.27%	84
2025 Q3	$2.77M	Buy	28,562 +6,487	+29%	+$672K	0.19%	114
2025 Q2	$2.36M	Buy	22,075 +944	+4%	+$95.5K	0.18%	122
2025 Q1	$2.15M	Buy	21,131 +2,061	+11%	+$208K	0.18%	135
2024 Q4	$1.71M	Buy	19,070 +319	+2%	+$28.1K	0.13%	176
2024 Q3	$1.57M	Hold	18,751	–	–	0.13%	183
2024 Q2	$1.44M	Buy	18,751 +1,391	+8%	+$102K	0.13%	162
2024 Q1	$1.19M	Buy	17,360 +15,804	+1,016%	+$1.02M	0.12%	184
2023 Q4	$90K	Buy	+1,556	New	+$83.1K	0.11%	167

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Plato Investment Management's BSX Position: Q2 2026 in Review

Plato Investment Management reduced its Boston Scientific (BSX) stake by 29% in Q2 2026, selling an estimated $672K and leaving 30,788 shares worth $1.31M. The position accounts for 0.07% of the portfolio, ranked #235.

Plato Investment Management first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $4.09M in Q4 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Plato Investment Management held 30,788 shares of Boston Scientific worth $1.31M as of Q2 2026.
Plato Investment Management sold 12,384 Boston Scientific shares in Q2 2026, an estimated $672K.
Boston Scientific made up 0.07% of Plato Investment Management's portfolio in Q2 2026, its #235 holding.
Plato Investment Management first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
Plato Investment Management's Boston Scientific position peaked at $4.09M in Q4 2025.
1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Plato Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.